UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 548

Sortiert nach

Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study

European archives of psychiatry and clinical neuroscience, 2014-03, Vol.264 (2), p.131-141

2014

Volltextzugriff (PDF)

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Molecular psychiatry, 2007-07, Vol.12 (7), p.671-680

2007

Volltextzugriff (PDF)

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

Acta psychiatrica Scandinavica, 2011-03, Vol.123 (3), p.228-238

2011

Volltextzugriff (PDF)

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Journal of Neural Transmission, 2006-11, Vol.113 (11), p.1771-1778

2006

Volltextzugriff (PDF)

A multi-criteria drought resistance assessment of temperate Acer, Carpinus, Fraxinus, Quercus, and Tilia species

Perspectives in plant ecology, evolution and systematics, 2024-03, Vol.62, p.125777, Article 125777

2024

Volltextzugriff (PDF)

Somnologics - Medicines for the Treatment of Sleep Disorders

Sleep medicine, 2022-12, Vol.100, p.S211

2022

Volltextzugriff (PDF)

Outcome of suicidal patients with schizophrenia: results from a naturalistic study

Acta psychiatrica Scandinavica, 2010-05, Vol.121 (5), p.359-370

2010

Volltextzugriff (PDF)

A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

International clinical psychopharmacology, 2001-09, Vol.16 (5), p.253-263

2001

Volltextzugriff (PDF)

Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010

The international journal of neuropsychopharmacology, 2015-02, Vol.18 (4), p.pyu080-pyu080

2015

Volltextzugriff (PDF)

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

Journal of Neural Transmission, 2000-01, Vol.107 (7), p.815-829

2000

Volltextzugriff (PDF)

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Psychiatric quarterly, 2021-03, Vol.92 (1), p.177-191

2021

Volltextzugriff (PDF)

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Experimental neurology, 2010-06, Vol.223 (2), p.366-370

2010

Volltextzugriff (PDF)

Seizures during antidepressant treatment in psychiatric inpatients-results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatriea[euro] (AMSP) 1993-2008

Psychopharmacology, 2013-11, Vol.230 (2), p.191-201

2013

Volltextzugriff (PDF)

Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008

Psychopharmacology, 2013-11, Vol.230 (2), p.191-201

2013

Volltextzugriff (PDF)

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Journal of neurochemistry, 2002-05, Vol.81 (3), p.481-496

2002

Volltextzugriff (PDF)

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

European psychiatry, 2015-01, Vol.30 (1), p.43-50

2015

Volltextzugriff (PDF)

combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI

The Journal of nutrition, health & aging, 2012, Vol.16 (6), p.544-548

2012

Volltextzugriff (PDF)

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

European psychiatry, 2012-11, Vol.27 (8), p.625-633

2012

Volltextzugriff (PDF)

Prof. Dr. Norbert Matussek

Nervenarzt, 2010-05, Vol.81 (5), p.607-608

2010

Volltextzugriff (PDF)

The AMSP drug safety program: methods and global results

Pharmacopsychiatry, 2004-03, Vol.37 Suppl 1, p.S4-11

2004

Volltextzugriff (PDF)

Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial

The journal of prevention of Alzheimer's disease, 2018, Vol.5 (3), p.202-206

2018

Volltextzugriff (PDF)

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin

Journal of neural transmission. Supplementum, 2002 (62), p.265

2002

Volltextzugriff (PDF)

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells

The Journal of biological chemistry, 2001-11, Vol.276 (46), p.42645-42657

2001

Volltextzugriff (PDF)

Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects

The journal of clinical psychiatry, 2005-08, Vol.66 (8), p.989

2005

Volltextzugriff (PDF)

1 – 25 von 548

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(287)
Mit Volltextzugriff
(450)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Deutsch
(325)
Englisch
(220)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

A multi-criteria drought resistance assessment of temperate Acer, Carpinus, Fraxinus, Quercus, and Tilia species

Somnologics - Medicines for the Treatment of Sleep Disorders

Outcome of suicidal patients with schizophrenia: results from a naturalistic study

A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease

Cardiovascular Adverse Reactions During Antidepressant Treatment: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2010

Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Seizures during antidepressant treatment in psychiatric inpatients-results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatriea[euro] (AMSP) 1993-2008

Seizures during antidepressant treatment in psychiatric inpatients—results from the transnational pharmacovigilance project “Arzneimittelsicherheit in der Psychiatrie” (AMSP) 1993–2008

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

Prof. Dr. Norbert Matussek

The AMSP drug safety program: methods and global results

Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial

Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells

Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects

Aktive Filter

Suchergebnisse filtern